189 related articles for article (PubMed ID: 8763834)
1. Physiological and pathological interrelationships of amyloid beta peptide and the amyloid precursor protein.
Larner AJ
Bioessays; 1995 Sep; 17(9):819-24. PubMed ID: 8763834
[TBL] [Abstract][Full Text] [Related]
2. Amyloid precursor protein (APP) and beta A4 amyloid in Alzheimer's disease and Down syndrome.
Beyreuther K; Dyrks T; Hilbich C; Mönning U; König G; Multhaup G; Pollwein P; Masters CL
Prog Clin Biol Res; 1992; 379():159-82. PubMed ID: 1409743
[No Abstract] [Full Text] [Related]
3. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-beta precursor protein processing in neurodegeneration.
Wilquet V; De Strooper B
Curr Opin Neurobiol; 2004 Oct; 14(5):582-8. PubMed ID: 15464891
[TBL] [Abstract][Full Text] [Related]
5. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
[TBL] [Abstract][Full Text] [Related]
6. Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms.
Cater MA; McInnes KT; Li QX; Volitakis I; La Fontaine S; Mercer JF; Bush AI
Biochem J; 2008 May; 412(1):141-52. PubMed ID: 18248325
[TBL] [Abstract][Full Text] [Related]
7. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
Mattson MP
Ann N Y Acad Sci; 1994 Dec; 747():50-76. PubMed ID: 7847692
[TBL] [Abstract][Full Text] [Related]
8. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT
Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131
[TBL] [Abstract][Full Text] [Related]
9. Amyloidogenic processing of beta-amyloid precursor protein in intracellular compartments.
Vetrivel KS; Thinakaran G
Neurology; 2006 Jan; 66(2 Suppl 1):S69-73. PubMed ID: 16432149
[TBL] [Abstract][Full Text] [Related]
10. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.
Kang J; Lemaire HG; Unterbeck A; Salbaum JM; Masters CL; Grzeschik KH; Multhaup G; Beyreuther K; Müller-Hill B
Nature; 1987 Feb 19-25; 325(6106):733-6. PubMed ID: 2881207
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
12. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
[TBL] [Abstract][Full Text] [Related]
13. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.
Joachim CL; Mori H; Selkoe DJ
Nature; 1989 Sep; 341(6239):226-30. PubMed ID: 2528696
[TBL] [Abstract][Full Text] [Related]
14. [Alzheimer's dementia and amyloid precursor-protein].
Blom N; Linnemann D
Ugeskr Laeger; 1992 Apr; 154(15):1010-5. PubMed ID: 1566508
[TBL] [Abstract][Full Text] [Related]
15. beta-Secretase, APP and Abeta in Alzheimer's disease.
Vassar R
Subcell Biochem; 2005; 38():79-103. PubMed ID: 15709474
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional and translational regulation of BACE1 expression--implications for Alzheimer's disease.
Rossner S; Sastre M; Bourne K; Lichtenthaler SF
Prog Neurobiol; 2006 Jun; 79(2):95-111. PubMed ID: 16904810
[TBL] [Abstract][Full Text] [Related]
17. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
[TBL] [Abstract][Full Text] [Related]
18. APPepsilon, the epsilon-secretase-derived N-terminal product of the beta-amyloid precursor protein, behaves as a type I protein and undergoes alpha-, beta-, and gamma-secretase cleavages.
Lefranc-Jullien S; Sunyach C; Checler F
J Neurochem; 2006 May; 97(3):807-17. PubMed ID: 16524370
[TBL] [Abstract][Full Text] [Related]
19. Intracellularly generated amyloid-beta peptide counteracts the antiapoptotic function of its precursor protein and primes proapoptotic pathways for activation by other insults in neuroblastoma cells.
Esposito L; Gan L; Yu GQ; Essrich C; Mucke L
J Neurochem; 2004 Dec; 91(6):1260-74. PubMed ID: 15584903
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism.
Vingtdeux V; Hamdane M; Gompel M; Bégard S; Drobecq H; Ghestem A; Grosjean ME; Kostanjevecki V; Grognet P; Vanmechelen E; Buée L; Delacourte A; Sergeant N
Neurobiol Dis; 2005 Nov; 20(2):625-37. PubMed ID: 15936948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
